Advertisement
New Zealand markets close in 3 hours 4 minutes
  • NZX 50

    12,408.13
    +98.22 (+0.80%)
     
  • NZD/USD

    0.5974
    -0.0008 (-0.13%)
     
  • NZD/EUR

    0.5483
    -0.0004 (-0.08%)
     
  • ALL ORDS

    8,217.00
    +50.60 (+0.62%)
     
  • ASX 200

    7,980.10
    +48.40 (+0.61%)
     
  • OIL

    79.95
    +0.17 (+0.21%)
     
  • GOLD

    2,405.00
    +10.30 (+0.43%)
     
  • NASDAQ

    19,822.87
    +300.25 (+1.54%)
     
  • FTSE

    8,198.78
    +43.06 (+0.53%)
     
  • Dow Jones

    40,415.44
    +127.91 (+0.32%)
     
  • DAX

    18,407.07
    +235.14 (+1.29%)
     
  • Hang Seng

    17,627.62
    -8.26 (-0.05%)
     
  • NIKKEI 225

    39,786.81
    +187.81 (+0.47%)
     
  • NZD/JPY

    93.5620
    -0.2540 (-0.27%)
     

With 48% ownership, Oceania Healthcare Limited (NZSE:OCA) has piqued the interest of institutional investors

Key Insights

  • Given the large stake in the stock by institutions, Oceania Healthcare's stock price might be vulnerable to their trading decisions

  • 51% of the business is held by the top 12 shareholders

  • Insiders have been buying lately

Every investor in Oceania Healthcare Limited (NZSE:OCA) should be aware of the most powerful shareholder groups. With 48% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.

ADVERTISEMENT

In the chart below, we zoom in on the different ownership groups of Oceania Healthcare.

View our latest analysis for Oceania Healthcare

ownership-breakdown
NZSE:OCA Ownership Breakdown January 12th 2024

What Does The Institutional Ownership Tell Us About Oceania Healthcare?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

Oceania Healthcare already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Oceania Healthcare's historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
NZSE:OCA Earnings and Revenue Growth January 12th 2024

Oceania Healthcare is not owned by hedge funds. Our data shows that BlackRock, Inc. is the largest shareholder with 12% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 9.8% and 5.0%, of the shares outstanding, respectively.

Looking at the shareholder registry, we can see that 51% of the ownership is controlled by the top 12 shareholders, meaning that no single shareholder has a majority interest in the ownership.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

Insider Ownership Of Oceania Healthcare

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Shareholders would probably be interested to learn that insiders own shares in Oceania Healthcare Limited. It has a market capitalization of just NZ$529m, and insiders have NZ$26m worth of shares, in their own names. It is good to see some investment by insiders, but it might be worth checking if those insiders have been buying.

General Public Ownership

The general public, who are usually individual investors, hold a 40% stake in Oceania Healthcare. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Private Company Ownership

Our data indicates that Private Companies hold 6.4%, of the company's shares. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Like risks, for instance. Every company has them, and we've spotted 2 warning signs for Oceania Healthcare (of which 1 is concerning!) you should know about.

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.